Program News and Releases
Governor Andrew M. Cuomo today announced $36 million has been awarded to three research groups for the development of treatments for some of the most devastating conditions that could be helped with stem cell research.
A new report from the lab of Viviane Tabar describes the ability to model a rare type of pediatric brain tumor for the first time using human embryonic stem cell-based techniques.
Governor Andrew M. Cuomo on August 6 announced that more than $14 million in funding is available to promote and support stem cell research in New York State. Stem cell science is widely viewed by experts as the key to understanding and treating many of the most devastating conditions affecting New Yorkers and people worldwide. The official press release can be found at http://www.governor.ny.gov/press/08062014-stem-cell-researchers
New research from the lab of Shahin Rafii identified a vascular niche that allows reprogramming and expansion of human hematopoietic progenitor cells capable of serial engraftment into mice.
New research from John Schimenti’s lab at Cornell sheds light on cell responses to DNA damage
Lorenz Studer and colleagues demonstrate how to differentiate human pluripotent stem cells into cranial placode.
New research from Carl Schildkraut identifies the mechanism leading to silencing of the FMR1 gene and resulting in Fragile X syndrome.
New research from Shahin Rafii’s lab reveals signaling pathways that regulate liver regeneration in response to damage.
Dr. Michel Sadelain, at Memorial Sloan-Kettering Cancer Center, was recognized for his efforts to develop a new stem cell-based therapy for β-thalassemia patients by the Sultan Bin Khalifa International Thalassemia Award.
A new paper from Shahin Rafii's lab profiles endothelial cells and finds they have tissue-specific characteristics.